Annovis Bio Inc. (ANVS)
NYSE: ANVS
· Real-Time Price · USD
2.73
0.01 (0.37%)
At close: Aug 15, 2025, 3:59 PM
2.72
-0.37%
After-hours: Aug 15, 2025, 05:59 PM EDT
Annovis Bio Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 17.13B | 22.24M | 10.55M | 12.64M | 4M | 3.14M | 5.75M | 6.35M | 15.72M | 16.76M | 28.38M | 31.99M | 35.97M | 42.67M | 45.69M | 47.46M | 49.22M | 5.6M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | -175 | 7.5K | n/a | n/a | 5.8K | 20.8K | 20.62K | 26.02K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 17.13B | 26.74M | 13.93M | 14.36M | 5.05M | 7.81M | 10.21M | 10.22M | 22.82M | 25.55M | 36.02M | 32.49M | 36.53M | 43.3M | 46M | 47.65M | 49.5M | 5.96M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Assets | 21.45B | 26.74M | 13.93M | 14.36M | 5.05M | 7.81M | 10.21M | 10.22M | 22.82M | 25.55M | 36.02M | 32.49M | 36.53M | 43.3M | 46M | 47.65M | 49.5M | 5.96M |
Account Payables | 974.31M | 1.37M | 2.31M | 4.1M | 3.39M | 4.11M | 1.29M | 1.93M | 1.17M | 4.15M | 3.96M | 1.85M | 901.84K | 929K | 688.07K | 289.74K | 114.83K | 824.57K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 2.81B | 844.32K | 1.21M | -38 | 275.25K | 499.07K | 2.89M | 1.24M | 640.68K | 1.13M | 3.18M | 209.13K | 149.61K | 158.92K | n/a | 587.17K | 380.81K | 379.23K |
Total Current Liabilities | 2.81B | 2.5M | 3.88M | 5.39M | 4.06M | 4.87M | 4.28M | 3.56M | 2.07M | 5.41M | 7.7M | 2.53M | 1.3M | 1.26M | 1.51M | 1.12M | 884.08K | 1.6M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 319M | 179K | 737K | 1.91M | 2.74M | 6.3M | 13.68M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 319M | 179K | 737K | 1.91M | 2.74M | 6.3M | 13.68M | n/a | n/a | 4.15B | 3.96M | 1.85M | 901.84K | 929K | 688.07K | n/a | n/a | n/a |
Total Liabilities | 3.12B | 2.68M | 4.62M | 7.3M | 6.8M | 11.17M | 17.96M | 3.56M | 2.07M | 5.41M | 7.7M | 2.53M | 1.3M | 1.26M | 1.51M | 1.12M | 884.08K | 1.6M |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock | 1.95M | 1.95K | 1.41K | 1.33K | 1.17K | 1.1K | 1.05K | 902.00 | 902.00 | 822.00 | 816.00 | 816.00 | 816.00 | 816.00 | 810.00 | 810.00 | 809.00 | 695.00 |
Retained Earnings | -146.61B | -140.39M | -134.85M | -128.98M | -116.35M | -111.33M | -110.26M | -88.05M | -73.33M | -63.79M | -54.05M | -50.96M | -43.34M | -34.62M | -28.73M | -22.81M | -19.96M | -17.44M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | 0.00 | n/a | 0.00 | n/a | 0.00 | n/a |
Shareholders Equity | 18.33B | 24.05M | 9.31M | 7.06M | -1.75M | -3.35M | -7.75M | 6.66M | 20.74M | 20.14M | 28.32M | 29.96M | 35.23M | 42.04M | 44.49M | 46.53M | 48.61M | 4.37M |
Total Investments | n/a | n/a | n/a | 12.62B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |